13 September 2017


There was a massage volume spike yesterday on ITEK. This is good news...it looks like rocket pharms is going to step and help ITEK through testing and some financial mergers. We're not sure why there was a dip in after hours...we find it hard to believe anyone was able to sell ITEK at at $1.37. Albeit, we went ahead and created a pending sale @ $1.30 and we will see if we can get it. We are starting to drill in a target price of $1.75. Now we may get out before then, but that's our value estimate. 

James PauleyComment